Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Neuron ; 112(16): 2765-2782.e9, 2024 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-38917805

RESUMO

Inhibitory interneurons in the dorsolateral geniculate nucleus (dLGN) are situated at the first central synapse of the image-forming visual pathway, but little is known about their function. Given their anatomy, they are expected to be multiplexors, integrating many different retinal channels along their dendrites. Here, using targeted single-cell-initiated rabies tracing, we found that mouse dLGN interneurons exhibit a degree of retinal input specialization similar to thalamocortical neurons. Some are anatomically highly specialized, for example, toward motion-selective information. Two-photon calcium imaging performed in vivo revealed that interneurons are also functionally specialized. In mice lacking retinal horizontal direction selectivity, horizontal direction selectivity is reduced in interneurons, suggesting a causal link between input and functional specialization. Functional specialization is not only present at interneuron somata but also extends into their dendrites. Altogether, inhibitory interneurons globally display distinct visual features which reflect their retinal input specialization and are ideally suited to perform feature-selective inhibition.


Assuntos
Corpos Geniculados , Interneurônios , Inibição Neural , Vias Visuais , Animais , Interneurônios/fisiologia , Camundongos , Corpos Geniculados/fisiologia , Corpos Geniculados/citologia , Vias Visuais/fisiologia , Inibição Neural/fisiologia , Retina/citologia , Retina/fisiologia , Dendritos/fisiologia , Tálamo/fisiologia , Tálamo/citologia , Camundongos Endogâmicos C57BL , Camundongos Transgênicos
2.
Artigo em Inglês | MEDLINE | ID: mdl-38565268

RESUMO

Retinal disorders caused by genetic or environmental factors cause severe visual impairment and often result in blindness. The past ten years have seen rapid progress in our understanding of the biological basis of these conditions, as well as significant advances towards gene and cell-based therapies. Regulatory challenges remain, but there is reason to hope that creative approaches will lead to safe and effective breakthrough treatments for these conditions in the near future.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA